Smith & Nephew (LON:SN) Insider David King Buys 2,800 Shares

Key Points

• Insider David King purchased 2,800 shares of Smith & Nephew at an average cost of GBX 3,631 per share, amounting to £101,668.
• Analyst ratings indicate an average of "Hold" for the stock, with target price revisions ranging from GBX 1,100 to GBX 1,438 by various financial institutions.
• Smith & Nephew has a market capitalization of £14.78 billion, with a price-to-earnings ratio of 48.53 and a debt-to-equity ratio of 70.22.

Smith & Nephew plc (LON:SN - Get Free Report) insider David King acquired 2,800 shares of the firm's stock in a transaction dated Monday, August 18th. The shares were purchased at an average price of GBX 3,631 per share, with a total value of £101,668.

Smith & Nephew Trading Down 0.1%

Smith & Nephew stock traded down GBX 2 during trading on Monday, hitting GBX 1,383. 2,379,900 shares of the company were exchanged, compared to its average volume of 343,671. The firm has a 50 day simple moving average of GBX 1,180.15 and a 200 day simple moving average of GBX 1,103.75. The company has a market capitalization of £15.16 billion, a P/E ratio of 49.79, a P/E/G ratio of 0.46 and a beta of 0.62. The company has a debt-to-equity ratio of 70.22, a current ratio of 2.51 and a quick ratio of 0.84.

Analysts Set New Price Targets

Several equities research analysts recently issued reports on the company. JPMorgan Chase & Co. upped their price target on Smith & Nephew from GBX 1,357 to GBX 1,438 and gave the stock an "overweight" rating in a report on Wednesday, August 6th. Berenberg Bank upped their price target on Smith & Nephew from GBX 1,100 to GBX 1,300 and gave the stock a "hold" rating in a report on Thursday, August 7th. Finally, Deutsche Bank Aktiengesellschaft upped their price target on Smith & Nephew from GBX 1,300 to GBX 1,400 and gave the stock a "hold" rating in a report on Wednesday, August 6th. One analyst has rated the stock with a Buy rating and two have issued a Hold rating to the stock. Based on data from MarketBeat, the company presently has an average rating of "Hold" and an average target price of GBX 1,379.33.

About Smith & Nephew

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.